MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on March 28, 2007; DOI: 10.1124/mol.106.032144


0026-895X/07/7201-8-17$20.00
Mol Pharmacol 72:8-17, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
mol.106.032144v1
72/1/8    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Niesler, B.
Right arrow Articles by Brüss, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Niesler, B.
Right arrow Articles by Brüss, M.

Characterization of the Novel Human Serotonin Receptor Subunits 5-HT3C,5-HT3D, and 5-HT3EFormula

Beate Niesler, Jutta Walstab, Sandra Combrink, Dorothee Möller, Johannes Kapeller, Jens Rietdorf, Heinz Bönisch, Manfred Göthert, Gudrun Rappold, and Michael Brüss

Department of Human Molecular Genetics, University of Heidelberg, Heidelberg, Germany (B.N., D.M., J.K., G.R.); Institute of Pharmacology and Toxicology, University of Bonn, Bonn, Germany (J.W., S.C., H.B., M.G., M.B.); and Advanced Light Microscopy Facility and Cell Biology/Cell Biophysics Programme, European Molecular Biology Laboratory, Heidelberg, Germany (J.R.)

Within the family of serotonin receptors, the 5-hydroxytryptamine-3 (5-HT3) receptor is the only ligand-gated ion channel. It is composed of five subunits, of which the 5-HT3A and 5-HT3B subunits are best characterized. Several studies, however, have reported on the functional diversity of native 5-HT3 receptors, which cannot solely be explained on the basis of the 5-HT3A and 5-HT3B subunits. After our discovery of further putative 5-HT3 serotonin receptor-encoding genes, HTR3C, HTR3D, and HTR3E, we investigated whether these novel candidates and the isoform 5-HT3Ea are able to form functional 5-HT3 receptor complexes. Using immunofluorescence and immunoprecipitation studies of heterologously expressed proteins, we found that each of the respective candidates coassembles with 5-HT3A. To investigate whether the novel subunits modulate 5-HT3 receptor function, we performed radioligand-binding assays and calcium-influx studies in human embryonic kidney 293 cells. Our experiments revealed that the 5-HT3C,5-HT3D, 5-HT3E, and 5-HT3Ea subunits alone cannot form functional receptors. Coexpression with 5-HT3A, however, results in the formation of functional heteromeric complexes with different serotonin efficacies. Potencies of two agonists and antagonists were nearly identical with respect to homomeric 5-HT3A and heteromeric complexes. However, 5-HT showed increased efficacy with respect to 5-HT3A/D and 5-HT3A/E receptors, which is consistent with the increased surface expression compared with 5-HT3A receptors. In contrast, 5-HT3A/C and 5-HT3A/Ea receptors exhibited decreased 5-HT efficacy. These data show for the first time that the novel 5-HT3 subunits are able to form heteromeric 5-HT3 receptors, which exhibit quantitatively different functional properties compared with homomeric 5-HT3A receptors.


Received October 24, 2006; accepted March 28, 2007

Address correspondence to: Dr. Beate Niesler, Department of Human Molecular Genetics, University of Heidelberg, Im Neuenheimer Feld 366, 69120 Heidelberg, Germany. E-mail: beate.niesler{at}med.uni-heidelberg.de




This article has been cited by other articles:


Home page
J. Physiol.Home page
Y. Noam, W. J. Wadman, and J. A. van Hooft
On the voltage-dependent Ca2+ block of serotonin 5-HT3 receptors: a critical role of intracellular phosphates
J. Physiol., August 1, 2008; 586(15): 3629 - 3638.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. R. Livesey, M. A. Cooper, T. Z. Deeb, J. E. Carland, J. Kozuska, Tim. G. Hales, J. J. Lambert, and J. A. Peters
Structural Determinants of Ca2+ Permeability and Conduction in the Human 5-Hydroxytryptamine Type 3A Receptor
J. Biol. Chem., July 11, 2008; 283(28): 19301 - 19313.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Krzywkowski, P. A. Davies, P. L. Feinberg-Zadek, H. Brauner-Osborne, and A. A. Jensen
High-frequency HTR3B variant associated with major depression dramatically augments the signaling of the human 5-HT3AB receptor
PNAS, January 15, 2008; 105(2): 722 - 727.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
K. B. Fink and M. Gothert
5-HT Receptor Regulation of Neurotransmitter Release
Pharmacol. Rev., December 1, 2007; 59(4): 360 - 417.
[Abstract] [Full Text] [PDF]


Home page
Mol Biol EvolHome page
A. M. Andres, C. de Hemptinne, and J. Bertranpetit
Heterogeneous Rate of Protein Evolution in Serotonin Genes
Mol. Biol. Evol., December 1, 2007; 24(12): 2707 - 2715.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics